LifeMD, Inc. is a publicly traded American telehealth company.[3] It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.[4]
History
The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001.[5] In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer.[6] The company changed its name to LifeMD in 2020 and started using the ticker name LFMD.[7][8]